Indian drugmaker Elder Pharmaceuticals plans to raise Rs 1.05 billion through seven -year bonds at 11.25%, two sources with direct knowledge of the deal told Reuters.
The bond features repayments in 10 equal semi-annual instalments commencing two years after the issue date, the sources said.
Proceeds from the secured non-convertible debenture issue will refinance existing higher cost debt, a senior company source told Reuters. Typically, long term debt comes at 12.5% to 13.5%, he added.
Almondz Global Securities is the sole arranger of the deal.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.